Denne oversettelsen klargjøres fortsatt. Inntil videre viser vi den engelske originalversjonen.

Selskapsmeldinger · 13.11.20261 min read

Leqembi® Pen subcutaneous treatment launched in Japan

Lokal automatisk oversettelse · Kildens originalspråk

Illustration generated by Business News; it is not a source photograph.

Sammendrag

STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…

Kildens originalspråk: PR Newswire UK — News ReleasesLes originalen →